Drug stocks mixed, Sequenom tanks on test delay
April 30, 2009 at 10:34 AM EDT
Drug stocks were mixed in early action Thursday as shares of biotech group Sequenom Inc. tanked on news that the launch of its new test for Down Syndrome will be delayed.
